Shoshana Shendelman, President and CEO, 10% Owner at Applied Therapeutics Inc. (APLT), sold 45,000 shares at $31.63 ($1.4M) on 2020-07-07, disclosed to the SEC on 2020-07-09.
Scheduled sale ($1.4M) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.63 | 1,995 | $63K | 4.4% |
| 2 | $32.25 | 13,005 | $419K | 29.3% |
| 3 | $32.21 | 12,889 | $415K | 29.0% |
| 4 | $32.98 | 2,111 | $70K | 4.9% |
| 5 | $30.90 | 10,936 | $338K | 23.6% |
| 6 | $31.64 | 4,064 |
| $129K |
| 9.0% |
| Total | $31.86 avg | 45,000 | $1.4M | 100% |
| Filing → |
| APLT | SELL | 2024-03-18 | $3.4M | — | Filing → |
| APLT | SELL | 2023-12-01 | $8K | — | Filing → |
| APLT | SELL | 2023-09-29 | $624K | — | Filing → |